Sir Niall Ferguson Joins The Times
The Times announces Sir Niall Ferguson has joined as a contributing writer and will write 12 exclusive pieces per year. He offers his unique insights…
Thought Leader: Niall Ferguson
By Scott Gottlieb (Original source AEI)
“Senior citizens are facing increasing and often significant burdens from rising out-of-pocket costs on drugs that they need to improve their health while many observers worry about the long run stability of the Part D program. As part of the Prescription Drug Pricing Reduction Act (PDPRA), the Senate Finance Committee is considering two significant reforms to the Medicare Part D program aimed at reducing overall program outlays and beneficiary out-of-pocket spending. Most notably, the proposal would substantially redesign the structure of the Part D benefit to encourage more efficient management of drug spending and reduce incentives that encourage rapid growth of list prices. In addition, it would establish mandatory rebates in Medicare Part D if list prices on drugs grow faster than the rate of inflation (as measured by CPI-U) to reduce enrollee out-of-pocket spending.”
Click here to see more
Sir Niall Ferguson Joins The Times
The Times announces Sir Niall Ferguson has joined as a contributing writer and will write 12 exclusive pieces per year. He offers his unique insights…
Thought Leader: Niall Ferguson
Dr. Sanjay Gupta: Is Ozempic Really A Miracle Drug?
New drugs like Wegovy, Ozempic and Mounjaro are billed as a revolutionary new approach for losing weight. But are these actually miracle drugs? Dr. Sanjay…
Thought Leader: Sanjay Gupta
Peter Zeihan: The Geopolitics of Climate Change
From Peter Zeihan: With a glacier as the backdrop for this video, I figured it only appropriate to discuss resource exploitation, Arctic shipping, and agriculture…
Thought Leader: Peter Zeihan